Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025 2026
Market Cap 1 91.84 79.88
Change - -13.02%
Enterprise Value (EV) 1 61.1 64.14
Change - 4.98%
P/E 21.2x 19.1x
PBR 1.04x 0.86x
PEG -1.1x -5.48x
Capitalization / Revenue 1.12x 0.84x
EV / Revenue 0.74x 0.68x
EV / EBITDA 7.34x 6.31x
EV / EBIT 16x 12.6x
EV / FCF - -
FCF Yield - -
Dividend per Share 2 - -
Rate of return - -
EPS 2 1.896 1.83
Distribution rate - -
Net sales 1 82.35 94.91
EBITDA 1 8.319 10.16
EBIT 1 3.821 5.079
Net income 1 3.947 4.179
Net Debt 1 -30.75 -15.75
Reference price 2 40.24 35.00
Nbr of stocks (in thousands) 2,282 2,282
Announcement Date 8/26/25 8/22/26
1INR in Million2INR
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 847K
-239.05x15.89x-284.84x-.--% 47.23B
23.79x2.17x12.27x0.88% 26.88B
15.74x1.25x7.09x5.56% 6.86B
1066x - - - 5.87B
52.07x9.6x33.07x0.96% 3.4B
-26.05x - - - 2.61B
-58.48x - - -.--% 2.24B
15.17x1.52x5.98x5.01% 2.14B
30.04x1.57x11.8x1.5% 1.83B
Average 97.69x 5.34x -35.77x 1.99% 9.91B
Weighted average by Cap. -42.57x 9.69x -146.32x 0.87%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited